Keyphrases
Dominant Negative
100%
Mouse Ventricular Myocytes
100%
Kv1.5
100%
Selective Elimination
100%
4-aminopyridine
50%
Mouse Model
25%
Electrophysiological Recordings
25%
Phenylalanine
25%
Transgenic Mice
25%
Specific Expression
25%
Attenuation
25%
Point mutation
25%
Tryptophan
25%
Myosin Heavy Chain (MyHC)
25%
Pore Region
25%
Channel Subunits
25%
Ventricular Myocytes
25%
Action Potential Duration
25%
Ventricular Arrhythmia
25%
Electrical Remodeling
25%
Non-conductive Material
25%
C57BL6
25%
Phenotypic Outcome
25%
QT Prolongation
25%
Three-line
25%
Voltage-gated K+ Channels
25%
Sensitive Characteristics
25%
Kv1.1
25%
Left Ventricular Myocyte
25%
Mouse Ventricle
25%
Ventricular Action Potential
25%
KCNA5
25%
Biochemistry, Genetics and Molecular Biology
4-Aminopyridine
100%
Transgene
50%
Mouse Model
50%
Transgenic Mouse
50%
Promoter Region
50%
Point Mutation
50%
Cardiac Dysrhythmia
50%
Heavy Meromyosin
50%
Action Potential Duration
50%
Electrophysiological Procedures
50%
Voltage-Gated Potassium Channel
50%
Kv1.1
50%
KCNA5
50%
Tryptophan
50%
Phenylalanine
50%
Medicine and Dentistry
4-Aminopyridine
100%
Transgene
50%
Promoter Region
50%
Transgenic Mouse
50%
Point Mutation
50%
Heavy Meromyosin
50%
Ventricle of Heart
50%
Heart Ventricle Arrhythmia
50%
Phenylalanine
50%
Tryptophan
50%
Action Potential Duration
50%
QT Prolongation
50%
Kv1.1
50%
KCNA5
50%
Voltage-Gated Potassium Channel
50%
Pharmacology, Toxicology and Pharmaceutical Science
Elimination
100%
4-Aminopyridine
100%
Mouse Model
50%
Transgenic Mouse
50%
Potassium Channel
50%
Phenylalanine
50%
Myosin Heavy Chain
50%
Heart Ventricle Arrhythmia
50%
Tryptophan
50%
QT Prolongation
50%
Neuroscience
Myocyte
100%
4-Aminopyridine
66%
Action Potential
33%
In Vivo
33%
Promoter Region
33%
Phenylalanine
33%
Cardiac Dysrhythmia
33%
Transgene
33%
Myosin Heavy Chain
33%
Point Mutation
33%
Voltage-Gated Potassium Channel
33%
Kv1.1
33%
Tryptophan
33%
KCNA5
33%